Risk factor
Very high price volatility
Profitability factor
Overvalued vs peers
About
BiOptic Inc. specializes as a biotechnology instrumentation firm, crafting scientific tools designed for both laboratory research and clinical applications. Their extensive product line features various instruments, including sophisticated bio-fragment analyzers and PCR thermocyclers. Additionally, they supply essential consumables such as cartridges for DNA, RNA, and protein analysis, alongside quantification kits. The company further provides specialized PCR reagents, encompassing premixed formulas and polymerases. Completing their offerings are diverse diagnostic kits tailored for veterinary, human, and food-related testing. Founded in 1993, BiOptic Inc. is headquartered in New Taipei City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA, trading